Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Tumor location is a risk factor for lymph node metastasis in superficial Barrett's adenocarcinoma.

Yamada M, Oda I, Tanaka H, Abe S, Nonaka S, Suzuki H, Yoshinaga S, Kuchiba A, Koyanagi K, Igaki H, Taniguchi H, Sekine S, Saito Y, Tachimori Y.

Endosc Int Open. 2017 Sep;5(9):E868-E874. doi: 10.1055/s-0043-115388. Epub 2017 Sep 12.

2.

Measurement of the tumor invasion depth into the submucosa in early adenocarcinoma of the esophagus (pT1b): Can microns be the new standard for the endoscopist?

Manner H, Pech O.

United European Gastroenterol J. 2015 Dec;3(6):501-4. doi: 10.1177/2050640615617724. No abstract available.

3.

Esophageal cancer: staging system and guidelines for staging and treatment.

Berry MF.

J Thorac Dis. 2014 May;6 Suppl 3:S289-97. doi: 10.3978/j.issn.2072-1439.2014.03.11. Review.

4.

Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma.

Landau MS, Hastings SM, Foxwell TJ, Luketich JD, Nason KS, Davison JM.

Mod Pathol. 2014 Dec;27(12):1578-89. doi: 10.1038/modpathol.2014.66. Epub 2014 Apr 25.

5.

Is Endoscopic Ultrasound (EUS) necessary in the pre-therapeutic assessment of Barrett's esophagus with early neoplasia?

Fernández-Sordo JO, Konda VJ, Chennat J, Madrigal-Hoyos E, Posner MC, Ferguson MK, Waxman I.

J Gastrointest Oncol. 2012 Dec;3(4):314-21. doi: 10.3978/j.issn.2078-6891.2012.038.

6.

The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.

Dunbar KB, Spechler SJ.

Am J Gastroenterol. 2012 Jun;107(6):850-62; quiz 863. doi: 10.1038/ajg.2012.78. Review.

7.

The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection.

Yoon HH, Khan M, Shi Q, Cassivi SD, Wu TT, Quevedo JF, Burch PA, Sinicrope FA, Diasio RB.

Mayo Clin Proc. 2010 Dec;85(12):1080-9. doi: 10.4065/mcp.2010.0421.

8.

Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy.

Mukherjee K, Chakravarthy AB, Goff LW, El-Rifai W.

Dig Dis Sci. 2010 Dec;55(12):3304-14. doi: 10.1007/s10620-010-1187-4. Epub 2010 Mar 19. Review.

9.

Epidemiology and biology of esophageal cancer.

Demeester SR.

Gastrointest Cancer Res. 2009 Mar;3(2 Suppl):S2-5.

10.

Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus.

Prasad GA, Wang KK, Halling KC, Buttar NS, Wongkeesong LM, Zinsmeister AR, Brankley SM, Fritcher EG, Westra WM, Krishnadath KK, Lutzke LS, Borkenhagen LS.

Gastroenterology. 2008 Aug;135(2):370-9. doi: 10.1053/j.gastro.2008.04.036. Epub 2008 May 7.

11.

Endoscopic mucosal resection in the upper gastrointestinal tract.

Ahmadi A, Draganov P.

World J Gastroenterol. 2008 Apr 7;14(13):1984-9. Review.

12.

Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus.

Prasad GA, Buttar NS, Wongkeesong LM, Lewis JT, Sanderson SO, Lutzke LS, Borkenhagen LS, Wang KK.

Am J Gastroenterol. 2007 Nov;102(11):2380-6. Epub 2007 Jul 19.

13.

An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus.

Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW.

Ann Surg. 2007 May;245(5):717-25.

14.

Endoscopic mucosal resection in the setting of Barrett's esophagus.

Lee JK, Enns R.

Can J Gastroenterol. 2007 Mar;21(3):151-4. No abstract available.

15.

Frozen section analysis of esophageal endoscopic mucosal resection specimens in the real-time management of Barrett's esophagus.

Prasad GA, Wang KK, Lutzke LS, Lewis JT, Sanderson SO, Buttar NS, Wong Kee Song LM, Borkenhagen LS, Burgart LJ.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):173-8.

16.

Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience.

Conio M, Repici A, Cestari R, Blanchi S, Lapertosa G, Missale G, Della Casa D, Villanacci V, Calandri PG, Filiberti R.

World J Gastroenterol. 2005 Nov 14;11(42):6650-5.

17.

Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection.

Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR.

Ann Surg. 2005 Oct;242(4):566-73; discussion 573-5.

18.

Vagal-sparing esophagectomy: a more physiologic alternative.

Banki F, Mason RJ, DeMeester SR, Hagen JA, Balaji NS, Crookes PF, Bremner CG, Peters JH, DeMeester TR.

Ann Surg. 2002 Sep;236(3):324-35; discussion 335-6.

19.

Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies.

Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR.

Ann Surg. 2001 Oct;234(4):520-30; discussion 530-1.

20.

Supplemental Content

Support Center